Видео ютуба по тегу Valor-Hcm

AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy
AHA 24: VALOR-HCM: Mavacamten in Patients with Obstructive HCM Referred for Septal Reduction Therapy
VALOR-HCM Shows Promise for Patients With Hypertrophic Cardiomyopathy (for Healthcare Professionals)
VALOR-HCM Shows Promise for Patients With Hypertrophic Cardiomyopathy (for Healthcare Professionals)
Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition
Achieving Next-Level HCM Care and Outcomes With Cardiac Myosin Inhibition
Discussing the VALOR-HCM Trial
Discussing the VALOR-HCM Trial
ACC CVRI: Journal Club: VALOR-HCM Trial - By Tess Calcagno
ACC CVRI: Journal Club: VALOR-HCM Trial - By Tess Calcagno
ACC 22: Findings from the VALOR-HCM Trial | Dr Milind Y Desai
ACC 22: Findings from the VALOR-HCM Trial | Dr Milind Y Desai
After Shocks with Dr. Milind Desai on the VALOR-HCM trial
After Shocks with Dr. Milind Desai on the VALOR-HCM trial
VALOR-HCM: Mavacamten in Obstructive Hypertrophic Cardiomyopathy
VALOR-HCM: Mavacamten in Obstructive Hypertrophic Cardiomyopathy
ESC TV at #ACC22 - Expert Insights on VALOR-HCM and MAVA-LTE Study
ESC TV at #ACC22 - Expert Insights on VALOR-HCM and MAVA-LTE Study
La SEC te lleva a ACC22 [IN] ∙ VALOR-HCM
La SEC te lleva a ACC22 [IN] ∙ VALOR-HCM
Drug Reduces the Need for Surgery in Nearly 90% of Patients with HCM, Cleveland Clinic Study Shows
Drug Reduces the Need for Surgery in Nearly 90% of Patients with HCM, Cleveland Clinic Study Shows
ENTENDENDO VCM HCM E CHCM - HEMATOLOGIA DE EXCELÊNCIA
ENTENDENDO VCM HCM E CHCM - HEMATOLOGIA DE EXCELÊNCIA
HCM Awareness Day - Session 2
HCM Awareness Day - Session 2
Pushing Back Against HCM: The Role of Cardiac Myosin Inhibitors
Pushing Back Against HCM: The Role of Cardiac Myosin Inhibitors
Clinical Trial Shows Drug is Effective in Nearly 80% of Patients with Hypertrophic Cardiomyopathy
Clinical Trial Shows Drug is Effective in Nearly 80% of Patients with Hypertrophic Cardiomyopathy
Removing Obstructions for Improved HCM Care: Leveling Up Diagnosis and Management
Removing Obstructions for Improved HCM Care: Leveling Up Diagnosis and Management
Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond
Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond
VALOR-HCM - mavacamten para Cardiomiopatia Hipertrófica
VALOR-HCM - mavacamten para Cardiomiopatia Hipertrófica
HCM Baixa ou Alta no Hemograma | Hemoglobina Corpuscular Média | Índices Hematimétricos
HCM Baixa ou Alta no Hemograma | Hemoglobina Corpuscular Média | Índices Hematimétricos
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in Non-obstructive Hypertrophic Cardiomyopathy
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in Non-obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment
Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment
HCM Awareness Day - Session 1
HCM Awareness Day - Session 1
View from the Thoraxcenter: AHA 24 Wrap-Up
View from the Thoraxcenter: AHA 24 Wrap-Up